{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:38:18Z","timestamp":1791920298035,"version":"4.3.4"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Pediatr Emer Care"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Previous research has demonstrated that accidental unsupervised ingestions (AUIs) were responsible for the majority of cough and cold medication (CCM) ingestions leading to significant adverse events (AEs) in children. The objective of this analysis was to characterize the role of AUIs in the morbidity associated with CCM exposure in children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This surveillance study collected data from 5 United States data sources from 2009 to 2016, in children younger than 6 years with an AE from an AUI involving at least 1 CCM over-the-counter pharmaceutical ingredient. An expert panel reviewed each case to determine causality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>From 4756 total cases reviewed, 3134 (65.9%) had an AE from an AUI determined to be at least potentially related to a CCM ingredient. The majority (61.3%) of cases occurred in children aged 2 to younger than 4 years. Most exposures occurred in the child's own residence (94.9%), and 43.8% were admitted to a health care facility (22.0% to a critical care unit). Dextromethorphan and diphenhydramine, when packaged alone or in combination products, contributed to 96.0% of AUIs. The most common specific products involved were single-ingredient pediatric liquid diphenhydramine (30.1%) and single-ingredient pediatric liquid dextromethorphan (21.4%). There were 3 deaths from solid diphenhydramine formulations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>There continues to be opportunities for the implementation of interventions to prevent AUIs of CCM in children. Additional emphasis on engineering controls, such as flow restrictors for liquid formulations targeting diphenhydramine and dextromethorphan products, represent additional opportunities to further reduce AEs from AUIs of CCM.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pec.0000000000002166","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T22:52:14Z","timestamp":1592952734000},"page":"e100-e104","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Adverse Events Related to Accidental Unintentional Ingestions From Cough and Cold Medications in Children"],"prefix":"10.1097","volume":"38","author":[{"given":"George Sam","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate M.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Banner","sequence":"additional","affiliation":[{"name":"Oklahoma Center for Poison and Drug Information, Oklahoma University College of Pharmacy, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Randall","family":"Bond","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Hope Africa University, Bujumbura, Burundi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph E.","family":"Kauffman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Missouri\u2014Kansas City School of Medicine, Kansas City, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Palmer","sequence":"additional","affiliation":[{"name":"Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian M.","family":"Paul","sequence":"additional","affiliation":[{"name":"Pediatrics and Public Health Sciences, Penn State College of Medicine, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Rapp-Olsson","sequence":"additional","affiliation":[{"name":"Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard C.","family":"Dart","sequence":"additional","affiliation":[{"name":"Rocky Mountain Poison and Drug Safety, Denver Health and Hospital Authority, Denver, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,23]]},"reference":[{"key":"bib1-20250504","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1542\/peds.2008-0498","article-title":"Cough and cold medication use by US children, 1999\u20132006: results from the slone survey","volume":"122","year":"2008","journal-title":"Pediatrics"},{"key":"bib2-20250504","doi-asserted-by":"crossref","first-page":"e20163070","DOI":"10.1542\/peds.2016-3070","article-title":"Safety profile of cough and cold medication use in pediatrics","volume":"139","year":"2017","journal-title":"Pediatrics"},{"key":"bib3-20250504","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.annemergmed.2008.09.015","article-title":"Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications","volume":"53","year":"2009","journal-title":"Ann Emerg Med"},{"key":"bib4-20250504","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1542\/peds.2007-3813","article-title":"Unexpected infant deaths associated with use of cough and cold medications","volume":"122","year":"2008","journal-title":"Pediatrics"},{"key":"bib5-20250504","first-page":"1180","article-title":"Revised product labels for pediatric over-the-counter cough and cold medicines","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bib6-20250504","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1542\/peds.2013-2236","article-title":"Cough and cold medication adverse events after market withdrawal and labeling revision","volume":"132","year":"2013","journal-title":"Pediatrics"},{"key":"bib7-20250504","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.jpeds.2013.04.054","article-title":"Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States poison centers","volume":"163","year":"2013","journal-title":"J Pediatr"},{"key":"bib8-20250504","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1542\/peds.2010-1839","article-title":"Adverse events from cough and cold medications after a market withdrawal of products labeled for infants","volume":"126","year":"2010","journal-title":"Pediatrics"},{"key":"bib9-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12874-018-0626-3","article-title":"Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children","volume":"18","year":"2018","journal-title":"BMC Medical Research Methodology"},{"key":"bib12-20250504","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amepre.2018.10.004","article-title":"Ingestion of over-the-counter liquid medications: emergency department visits by children aged less than 6 years, 2012\u20132015","volume":"56","year":"2019","journal-title":"Am J Prev Med"},{"key":"bib13-20250504","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jpeds.2013.05.045","article-title":"Efficacy of flow restrictors in limiting access of liquid medications by young children","volume":"163","year":"2013","journal-title":"J Pediatr"},{"key":"bib14-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jpeds.2018.02.033","article-title":"Frequency of poison center exposures for pediatric accidental unsupervised ingestions of acetaminophen after the introduction of flow restrictors","volume":"198","year":"2018","journal-title":"J Pediatr"},{"key":"bib15-20250504","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.amepre.2018.12.015","article-title":"Flow restrictors and reduction of accidental ingestions of over-the-counter medications","volume":"56","year":"2019","journal-title":"Am J Prev Med"},{"key":"bib16-20250504","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jat\/27.7.523","article-title":"Fatal cold medication intoxication in an infant","volume":"27","year":"2003","journal-title":"J Anal Toxicol"},{"key":"bib17-20250504","first-page":"425","article-title":"Fatal diphenhydramine intoxication in infants","volume":"48","year":"2003","journal-title":"J Forensic Sci"},{"key":"bib18-20250504","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/15563650.2010.527850","article-title":"Status epilepticus and wide-complex tachycardia secondary to diphenhydramine overdose","volume":"48","year":"2010","journal-title":"Clin Toxicol"},{"key":"bib19-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.paf.0000188093.45675.ee","article-title":"Fatality from diphenhydramine monointoxication: a case report and review of the infant, pediatric, and adult literature","volume":"27","year":"2006","journal-title":"Am J Forensic Med Pathol"},{"key":"bib20-20250504","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1191\/096032700671040438","article-title":"Dose-dependent toxicity of diphenhydramine overdose","volume":"19","year":"2000","journal-title":"Hum Exp Toxicol"},{"key":"bib21-20250504","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jpeds.2010.05.040","article-title":"Malicious use of pharmaceuticals in children","volume":"157","year":"2010","journal-title":"J Pediatr"},{"key":"bib22-20250504","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/PEC.0b013e31821d860f","article-title":"Illicit drug exposure in patients evaluated for alleged child abuse and neglect","volume":"27","year":"2011","journal-title":"Pediatr Emerg Care"},{"key":"bib23-20250504","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.chiabu.2012.01.001","article-title":"Evaluation and referral for child maltreatment in pediatric poisoning victims","volume":"36","year":"2012","journal-title":"Child Abuse Negl"}],"container-title":["Pediatric Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T18:11:41Z","timestamp":1746382301000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PEC.0000000000002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,23]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pec.0000000000002166","relation":{},"ISSN":["1535-1815","0749-5161"],"issn-type":[{"value":"1535-1815","type":"electronic"},{"value":"0749-5161","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,23]]}}}